The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients With Psoriatic Arthritis - AcademicCME

The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients With Psoriatic Arthritis

1.0

Claim your AMA PRA Category 1 Credit or CNE Contact Hour

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

course Faculty

No data was found

Related Courses

Des experts internationaux évaluent de nouvelles données sur l’inhibition de l’aldostérone...

Gastroenterology

Integrating Next-Generation Acid Suppression into Practical Algorithms for Gastroenterolog...

PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians